Eliptica is leading DCAD, an Innovate UK-funded project investigating better diagnostics for coronary artery disease through proteomics and artificial intelligence. The total project grant is £679,134 across the participating organisations.

DCAD focuses on analysing proteins to identify patterns associated with coronary artery disease. The research aims to support better risk assessment and more precise patient stratification.

Project details: DCAD (Developing better diagnostics for Coronary Artery Disease with novel AI-enhanced, ultra fast proteomics). Funder: Innovate UK. Programme: Advancing Precision Medicine. UKRI reference: 10072712. Recorded project period: August 2023 to August 2025.

Further information

• UKRI project record